Navigation Links
New Report 'Looking at Chiral Technologies' Analyzes the Global,Market Growth Forecasts Driven By Two Very Important Components as,Single Isomer Drugs and Single Enantiomer Pharmaceuticals

DUBLIN, Ireland--(BUSINESS WIRE)--Jun 21, 2007 - Research and Markets (http://www.researchandmarkets.com/reports/c60415) has announced the addition of Looking at Chiral Technologies to their offering.

The advancements in molecular research and continued untiring efforts of the research industry to develop better more precisely applicable Pharmaceuticals as well as agro compounds would have not been possible without the advent of Chiral technologies and their applications.

The usage of chiral molecules is at the very centre of this technological revolution when coupled with the application of chiral technologies as: Chiral Pool, Resolution, Biocatalysts, or asymmetric analysis creates the required compounds. The majority of development activity is routed through fine chemical companies which are additionally trying to upgrade their capabilities in order to provide to the entire portfolio of pharmaceutical drugs for application in the consumer arena.

Such ramping up of operations by companies in order to develop and upgrade basic molecules for wide ranging applications is also bringing the focus of chiral technologies into the development of clinical cures.

This report - Looking at Chiral Technologies - introduces the concept of Chiral Technologies supplementing it with its variants and explaining the actions undertaken by the industry towards developing such compounds jointly and deriving common benefits of clinical nature. The report also analyzes the global market growth forecasts driven by two very important components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals which are synthesized in bulk nature which are contributing to deriving drug streams worldwide.

The report explains the sales of Single Enantiomer pharma on a YOY basis, which is being controlled by certain regulatory constraints. The report also presents an insight on the synergies developed by the industr
'"/>




Page: 1 2

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
(Date:6/29/2015)... ... June 29, 2015 , ... National HealthCare Associates recently released ... for the 40-center nursing home group. Sixteen of their centers were rated “Best ... States in one or more customer service areas. Those centers received the prestigious ...
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, a ... certain neuropsychiatric and chronic pain conditions, has announced appointments to three key leadership ... Peter Donato, Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior Vice ...
(Date:6/29/2015)... ... June 29, 2015 , ... New research released today at ... percent of U.S. state and local governments have implemented Next Generation 9-1-1 (NG9-1-1) ... NG9-1-1. , “Mobile phones have surpassed land lines as the primary mode ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... of two leaders with the Commercial Markets division, which includes the company’s commercial ... and Minnesota-headquartered companies with regional, national and international reach. Mary Ellen Anderson now ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... US Travel Guide for Wheelchair Users as a new e-book on Amazon.com. Wheel:Life ... , These accessible travel suggestions were crowdsourced by the Get Out & ...
Breaking Medicine News(10 mins):Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 2Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 3Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 3
... CISCO,Avaya.Linkys and More. , ... Hertfordshire, UK (PRWEB) January ... Call -Management Software Software, Call-Shadow V.5 is now available in 64 ... been looking at enhanced platform support for a while" said Shadow ...
... 28, 2009 Physical therapists at UT Southwestern Medical Center ... from neurological injuries such as strokes and traumatic brain injury ... movements needed to regain arm strength and movement. , UT ... how the Armeo device, with its virtual environment and weight ...
... Services will be Relocated to Adjacent Proton Site ... Hospital (CDH) received Illinois state approval on its ... and imaging center in Warrenville. The Illinois Health ... of 4-0, approved the project,s Certificate of Need ...
... Track Boehner and Republican Party on Wrong TrackSACRAMENTO, Calif., ... Boehner wrongly claimed that the Medicaid Family Planning State ... care to millions of women, would cost hundreds of ... of Boehner,s misleading attacks and partisan politics, was dropped ...
... Healthcare Company Recognized 5 years in a RowEL SEGUNDO, ... of kidney care services, has been honored for the ... one of the Top 125 ranked companies of employee-sponsored ... company to receive the recognition for five consecutive years, ...
... Despite recommendations and being at an increased risk of breast ... for a childhood cancer do not undergo appropriate mammography screening, ... JAMA . , Women treated with chest radiation for ... cancer at a young age. "The risk of breast cancer ...
Cached Medicine News:Health News:Call- Shadow IP Call Management Software, V.5. Now 64 bit with SIP and Enhanced Platform Support 2Health News:Call- Shadow IP Call Management Software, V.5. Now 64 bit with SIP and Enhanced Platform Support 3Health News:Physical therapists test mechanical arm to help patients recover from stroke, traumatic brain injury 2Health News:Physical therapists test mechanical arm to help patients recover from stroke, traumatic brain injury 3Health News:Central DuPage Hospital Wins State Approval to Build Cancer Center 2Health News:Central DuPage Hospital Wins State Approval to Build Cancer Center 3Health News:Family Planning Provision Wrongfully Removed From Economic Stimulus Package 2Health News:DaVita Training Programs Awarded Top Honor 2Health News:Many women who survived childhood cancer do not undergo recommended breast cancer screening 2
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: